Peer Exchange

Tap into peer-to-peer dialogues covering different therapeutic areas in easy to digest videos, featuring managed care thought leaders.

Treatment of Anemia in CKD
July 14, 2020 – 
The panel assesses the appropriate time to begin treatment of anemia in CKD as well as goals of therapy.
Payer Perspective of Anemia in CKD
July 14, 2020 – 
A discussion on the health care resource utilization in a patient with anemia in CKD and the importance of monitoring hemoglobin levels for treatment.
Chronic Fibrosing ILD With Progressive Phenotype: Clinical Burden
July 13, 2020 – 
Shared insight on the clinical burden of chronic fibrosing interstitial lung disease with progressive phenotype, including first-hand patient experience.
Chronic Fibrosing ILD With Progressive Phenotype: Economic Burden
July 13, 2020 – 
Practical perspectives on the economic burden of chronic fibrosing interstitial lung disease with progressive phenotype.
Risk Assessment for Cardiovascular Disease
July 10, 2020 – 
Risk factors that are commonly associated with cardiovascular disease.
Economic Burden of Cardiovascular Disease
July 10, 2020 – 
Eric Cannon, PharmD, FAMCP, highlights the main drivers that contribute to the economic burden of cardiovascular disease.
Value-Based Care vs Cost of Treatment for mBC
July 10, 2020 – 
Steven Peskin, MD, MBA, FACP provides an understanding of value-based care vs cost for therapy.
Role of Anemia in CKD
July 08, 2020 – 
Why patients with chronic kidney disease frequently develop anemia and the impact of anemia on quality of life.
Overview of Chronic Kidney Disease
July 08, 2020 – 
The panel provides an overview of chronic kidney disease [CKD] and the timeline to progression into end-stage renal disease.
Provider Responsibility to Cost Burden for mBC Therapy
July 08, 2020 – 
A discussion among the panelists on the provider’s responsibility to the cost burden of therapy.
Copyright AJMC 2006-2020 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.